DE69129812D1 - Antithrombogene und/oder antimikrobielle zusammensetzung - Google Patents

Antithrombogene und/oder antimikrobielle zusammensetzung

Info

Publication number
DE69129812D1
DE69129812D1 DE69129812T DE69129812T DE69129812D1 DE 69129812 D1 DE69129812 D1 DE 69129812D1 DE 69129812 T DE69129812 T DE 69129812T DE 69129812 T DE69129812 T DE 69129812T DE 69129812 D1 DE69129812 D1 DE 69129812D1
Authority
DE
Germany
Prior art keywords
reacted
quaternary ammonium
ionic surfactants
antithromogic
antimicrobial composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129812T
Other languages
English (en)
Other versions
DE69129812T2 (de
Inventor
Richard Whitbourne
Margaret Mangan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Biocoatings Corp
Original Assignee
STS Biopolymers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STS Biopolymers Inc filed Critical STS Biopolymers Inc
Application granted granted Critical
Publication of DE69129812D1 publication Critical patent/DE69129812D1/de
Publication of DE69129812T2 publication Critical patent/DE69129812T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69129812T 1990-07-12 1991-05-02 Antithrombogene und/oder antimikrobielle zusammensetzung Expired - Fee Related DE69129812T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55192490A 1990-07-12 1990-07-12
US66245291A 1991-02-28 1991-02-28
PCT/US1991/002868 WO1992000747A1 (en) 1990-07-12 1991-05-02 Anti-thrombogenic and/or anti-microbial composition

Publications (2)

Publication Number Publication Date
DE69129812D1 true DE69129812D1 (de) 1998-08-20
DE69129812T2 DE69129812T2 (de) 1999-02-11

Family

ID=27069899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129812T Expired - Fee Related DE69129812T2 (de) 1990-07-12 1991-05-02 Antithrombogene und/oder antimikrobielle zusammensetzung

Country Status (7)

Country Link
EP (1) EP0626854B1 (de)
AT (1) ATE168269T1 (de)
CA (1) CA2087102C (de)
DE (1) DE69129812T2 (de)
DK (1) DK0626854T3 (de)
ES (1) ES2120961T3 (de)
WO (1) WO1992000747A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331616T2 (de) * 1992-09-26 2002-08-01 Aventis Bulk S P A Zentrale Venenkatheter mit aufgebrachtem Lipodalbaheptid-Antibiotikum zur Vermeidung von katheterbezogenen Infektionen
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US5532311A (en) * 1995-02-01 1996-07-02 Minnesota Mining And Manufacturing Company Process for modifying surfaces
US5583213A (en) * 1995-05-12 1996-12-10 Minnesota Mining And Manufacturing Company Process to activate sulfated polysaccharides
US6051017A (en) * 1996-02-20 2000-04-18 Advanced Bionics Corporation Implantable microstimulator and systems employing the same
US5916585A (en) * 1996-06-03 1999-06-29 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto biodegradable polymers
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6197289B1 (en) 1997-07-01 2001-03-06 Terumo Cardiovascular Systems Corporation Removal of biologically active agents
US5945457A (en) * 1997-10-01 1999-08-31 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science Process for preparing biologically compatible polymers and their use in medical devices
JP3228409B2 (ja) * 1997-12-05 2001-11-12 東洋紡績株式会社 血液適合性組成物および医療用具
KR100591027B1 (ko) * 1997-12-26 2006-06-22 아스텔라스세이야쿠 가부시키가이샤 서방성 의약 조성물
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
IL142132A0 (en) 1998-09-23 2002-03-10 Phycogen Inc Methods and compositions for treating receptor mediated diseases
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US6156373A (en) * 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
JP2004511297A (ja) 2000-10-16 2004-04-15 コナー　メドシステムズ，　インコーポレイテッド 有益な薬剤を搬送するための拡張可能な医療装置
DE60231209D1 (de) * 2001-06-05 2009-04-02 Toyo Boseki Antithrombotische zusammensetzungen und diese enthaltende medizinische instrumente

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
US4871357A (en) * 1986-01-21 1989-10-03 Baxter International Inc. Ionic heparin coating
WO1989005138A1 (en) * 1987-12-08 1989-06-15 Mark Chasin Method of forming bioerodible implants for improved controlled drug release
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same

Also Published As

Publication number Publication date
DE69129812T2 (de) 1999-02-11
EP0626854A4 (de) 1993-09-02
ES2120961T3 (es) 1998-11-16
DK0626854T3 (da) 1999-04-19
CA2087102A1 (en) 1992-01-13
EP0626854B1 (de) 1998-07-15
WO1992000747A1 (en) 1992-01-23
ATE168269T1 (de) 1998-08-15
EP0626854A1 (de) 1994-12-07
CA2087102C (en) 2002-04-23

Similar Documents

Publication Publication Date Title
DE69129812D1 (de) Antithrombogene und/oder antimikrobielle zusammensetzung
DE69109351T2 (de) Antimikrobielle Zusammensetzung.
NZ222149A (en) Disinfectant compositions containing quaternary ammonium compounds and/or substituted guanidine anti-microbial agents
FI103751B1 (fi) Mikrobien vastaisia koostumuksia
BR9101256A (pt) Composto,composicao fungicida,processo fungicida,composicao inseticida ou acaricida e processo inseticida ou acaricida
DK0533017T3 (da) Vandbaserede, opløsningsmiddel- og emulgatorfrie mikrobicide kombinationer af aktive stoffer
FR2692755B1 (fr) Composition antimicrobienne.
DE69105462T2 (de) Desinfizierende Zusammensetzung.
DE69105870T2 (de) Kationische Verbindung und Reinigungsmittelzusammensetzung.
ITFI930083A0 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
ES2099087T3 (es) Composicion anti-trombogena y/o antimicrobiana.
ES2066196T3 (es) Compuesto de amonio, composicion que lo contiene y procedimiento de desinfeccion.
DE69103427D1 (de) Chemische zusammensetzungen.
BR9712954A (pt) Heterociclos de nitrogênio quaternários, processos para sua preparação e seu emprego como composições praguicidas
BR9100315A (pt) Composto,composicao lubrificante,metodo de estabilizacao de lubrificantes
ITRM910387A0 (it) Composto di dicloroanilina, composizioni che lo contengono e relativo metodo di preparazione.
DE69006282D1 (de) Keimtötende Zusammensetzung.
BR9105938A (pt) Composto anti-microbiano,composicao anti-microbiana,processo para preparacao de um composto anti-microbiano e processo de uso de um composto antimicrobiano
DE69003126T2 (de) Chemische Zusammensetzungen.
MX9102687A (es) Cianurato de piperazina y composiciones polimericas que lo contienen.
FR2661185B1 (fr) Compositions de peinture en relief.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ANGIOTECH BIOCOATINGS CORP., HENRIETTA, N.Y., US

8339 Ceased/non-payment of the annual fee